FDA Office Of Combination Products To Clarify Review Assignment Process
Executive Summary
FDA's Office of Combination Products plans to publish regulations or guidances to clarify the agency's mandate to assign review of combination products according to their primary mode of action
You may also be interested in...
FDA Combo Product Letters Tackle Postmarketing Issues; Guidance Planned
FDA's Office of Combination Products plans to issue guidance on postmarketing requirements included in "request for designation" letters
FDA Combo Product Letters Tackle Postmarketing Issues; Guidance Planned
FDA's Office of Combination Products plans to issue guidance on postmarketing requirements included in "request for designation" letters
FDA Combination Product Review Policy Update Includes Tracking System
FDA drug and biologic reviewers should track consultative or collaborative reviews on combination products through each center's tracking system, a Feb. 14 update to the agency's policies and procedures states